Skip to main content

TNF inhibitor

      Virtual EULAR 2020 Round Up
      In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include the SELECT-CHOICE study, the EXCEED trial, Avacopan in AAV, BeST mortality outcomes, BLISS-LN study, biosimilars and tofa in systemic sclerosis.
      These were my top abstracts from Thursday, 4th of June at EULAR 2020:
      These were my top abstracts from Thursday, 4th of June at EULAR 2020:
      SELECT-Choice: UPA vs ABA in RA

      Dr. Jack Cush from EULAR2020 Virtual Conference

      OP0151

      Updated EULAR Recommendations for RA Management

      Dr. Kathryn Dao from EULAR2020 Virtual Conference

      Imaging and Remission Axial Spondyloarthritis

      Dr. Olga Petryna from EULAR2020 Virtual Conference

      OP0079 - what MRI findings are most predictive in AxSpa

      OP0314 - Drug free remission in AxSpA

      Biosimilars in Spondyloarthritis

      Dr. Rachel Tate from EULAR2020 Virtual Conference 0632

      - ETN Biosimilar in Reactive Arthritis 0650

      - Treasure Study in infliximab biosimilar in SpA

      RT @drdavidliew: Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis?

      @Yuz6Yusof found

      David Liew drdavidliew

      5 years 1 month ago
      Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis? @Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats) Something to consider in these difficult-to-treat pts? @LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU
      RT @KDAO2011: #EULAR2020 Dr. V Ritschl:EULAR Task Force on Patient Adherance: 30-80% of pts do not adhere to Rx. resulti

      k dao KDAO2011

      5 years 1 month ago
      #EULAR2020 Dr. V Ritschl:EULAR Task Force on Patient Adherance: 30-80% of pts do not adhere to Rx. resulting in ⬆️dz severity, pain, fatigue, depression, decreased in function, physical activity. HCPs should discuss adherance reg. & explore factors affecting adherance. @RheumNow
      RT @Janetbirdope: ENbrel works in long term for the few people left on the drug at 10 yrs with SpA. Enormous dropout. If

      Janet Pope Janetbirdope

      5 years 1 month ago
      ENbrel works in long term for the few people left on the drug at 10 yrs with SpA. Enormous dropout. If you are still on Rx for a decade you are in the minority. Drop out of TNFi in SpA mirrors RA & PsA @RheumNow @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/dLS2fw5uRP
      RT @uptoTate: Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before

      Dr. Rachel Tate uptoTate

      5 years 1 month ago
      Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before or during pregnancy. Few on TNFi were continued on tx during pregnancy. #EULAR2020 @RheumNow https://t.co/t7B6pASeWQ https://t.co/BwU6RF5Qkn
      RT @uptoTate: Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 pat

      Dr. Rachel Tate uptoTate

      5 years 1 month ago
      Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 patients within the first 5 months. New-onset MEM is also observed in up to 15% of patients with IBD treated with VDZ. #EULAR2020 @RheumNow https://t.co/ZVjZC7hvxs https://t.co/d1RT3GzB2b
      RT @KDAO2011: #EULAR2020 Recc for irAEs w/ICI:
      1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcep

      k dao KDAO2011

      5 years 1 month ago
      #EULAR2020 Recc for irAEs w/ICI: 1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcept life-threatening myositis 2. Myositis beware bulbar signs: dysphagia, dysarthria, dysphonia: stop ICIs,⬆️GC, IVIG/PE 3. Don't test autoAbs b/f ICI Rx https://t.co/P5jDgnjK94
      RT @Janetbirdope: Don’t forget significant fibrosis with ILD has +RCT with nintedanib INBUILD study. Lots of buzz of R

      Janet Pope Janetbirdope

      5 years 1 month ago
      Don’t forget significant fibrosis with ILD has +RCT with nintedanib INBUILD study. Lots of buzz of RA ILD where MTX is OK, TNFi may have more ILD than other bDMARDs, biomatkers KL-6 @eular_org OP0038 #EULAR2020 @CRASCRRheum https://t.co/OihF3LmNYQ
      ×